Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2 Receptor Agonists

被引：87
|
作者：
Tabrizi, Mojgan Aghazadeh [1 ]
Baraldi, Pier Giovanni [1 ]
Borea, Pier Andrea [2 ]
Varani, Katia [2 ]
机构：
[1] Univ Ferrara, Dept Chem & Pharmaceut Sci, I-44121 Ferrara, Italy
[2] Univ Ferrara, Dept Med Sci, Pharmacol Sect, I-44121 Ferrara, Italy
来源：
CHEMICAL REVIEWS | 2016年 / 116卷 / 02期
关键词：
ACID AMIDE HYDROLASE; ISCHEMIA-REPERFUSION INJURY; N-ARYLAMIDE OXADIAZOLES; ENDOCANNABINOID SYSTEM; NEUROPATHIC PAIN; IN-VIVO; ANALGESIC ACTIVITY; TYPE-2; RECEPTOR; TUMOR-GROWTH; DIFFERENTIAL EXPRESSION;
D O I：
10.1021/acs.chemrev.5b00411
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
[No abstract available]
引用
收藏
页码：519 / 560
页数：42
相关论文
共 50 条
  • [1] The role of the cannabinoid CB2 receptor in pain transmission and therapeutic potential of small molecule CB2 receptor agonists
    Whiteside, G. T.
    Lee, G. P.
    Valenzano, K. J.
    CURRENT MEDICINAL CHEMISTRY, 2007, 14 (08) : 917 - 936
  • [2] Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists
    Han, Sangdon
    Thatte, Jayant
    Buzard, Daniel J.
    Jones, Robert M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (21) : 8224 - 8256
  • [3] Recent Advances on Type-2 Cannabinoid (CB2) Receptor Agonists and their Therapeutic Potential
    Gasperi, Valeria
    Guzzo, Tatiana
    Topai, Alessandra
    Gambacorta, Nicola
    Ciriaco, Fulvio
    Nicolotti, Orazio
    Maccarrone, Mauro
    CURRENT MEDICINAL CHEMISTRY, 2023, 30 (12) : 1420 - 1457
  • [4] The CB2 cannabinoid receptor as a therapeutic target in the central nervous system
    Cabanero, David
    Martin-Garcia, Elena
    Maldonado, Rafael
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2021, 25 (08) : 659 - 676
  • [5] Updating the Chemistry and Biology of Cannabinoid CB2 Receptor-Specific Inverse Agonists
    Lunn, Charles A.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2010, 10 (08) : 768 - 778
  • [6] Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update
    Morales, Paula
    Hernandez-Folgado, Laura
    Goya, Pilar
    Jagerovic, Nadine
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2016, 26 (07) : 843 - 856
  • [7] Switching cannabinoid response from CB2 agonists to FAAH inhibitors
    Tourteau, Aurelien
    Leleu-Chavain, Natascha
    Body-Malapel, Mathilde
    Andrzejak, Virginie
    Barczyk, Amelie
    Djouina, Madjid
    Rigo, Benoit
    Desreumaux, Pierre
    Chavatte, Philippe
    Millet, Regis
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (05) : 1322 - 1326
  • [8] Novel azoles as potent and selective cannabinoid CB2 receptor agonists
    Harnett, Jeremiah J.
    Dolo, Christine
    Viossat, Isabelle
    Auger, Florence
    Ferrandis, Eric
    Bigg, Dennis
    Auguet, Michel
    Auvin, Serge
    Chabrier, Pierre-E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (01) : 88 - 91
  • [9] CB2 Cannabinoid Receptor as a Potential Target in Myocardial Infarction: Exploration of Molecular Pathogenesis and Therapeutic Strategies
    More, Sagar A.
    Deore, Rucha S.
    Pawar, Harshal D.
    Sharma, Charu
    Nakhate, Kartik T.
    Rathod, Sumit S.
    Ojha, Shreesh
    Goyal, Sameer N.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (03)
  • [10] Single nucleotide polymorphisms in the cannabinoid CB2 receptor: Molecular pharmacology and disease associations
    Foyzun, Tahira
    Whiting, Maddie
    Velasco, Kate K.
    Jacobsen, Jessie C.
    Connor, Mark
    Grimsey, Natasha L.
    BRITISH JOURNAL OF PHARMACOLOGY, 2024, 181 (15) : 2391 - 2412
12345